December 28, 2022
Via: GENMonoclonal antibody makers should consider swapping batch for continuous production, according to research suggesting new tech has made switching less of a risky endeavor. The study looked at the benefits of converting downstream processes and found that if done properly, […]
July 11, 2024
July 11, 2024
July 19, 2024